Education

Site Preparation for Establishing 177Lu-Radioligand Therapy Programs



There's a New PET Drug in Town: Manufacturing and Approval Consideration
for Your Institution


Theranostics: Regulatory Considerations for Product Development


SNMMI/NCI Third Targeted Radionuclide Therapy Conference 2019

Guidance Documents

Charging for Investigational Drugs Under an IND - Questions and Answers
Guidance for Industry - June 2016




Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers
Guidance for Industry - June 2016

Therapy Implementation Checklist

• Radiopharmaceutical Therapy Toolkit Checklist (PDF)
• Radiopharmaceutical Therapy Toolkit Checklist (MS Word)

Tools for Technologists

Publications

• Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division
• For more articles on nuclear medicine therapy from SNMMI journals, click here.